196 related articles for article (PubMed ID: 32699225)
1. A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells.
Ahmed AA; Marchetti C; Ohnmacht SA; Neidle S
Sci Rep; 2020 Jul; 10(1):12192. PubMed ID: 32699225
[TBL] [Abstract][Full Text] [Related]
2. A G-Quadruplex-Binding Small Molecule and the HDAC Inhibitor SAHA (Vorinostat) Act Synergistically in Gemcitabine-Sensitive and Resistant Pancreatic Cancer Cells.
Ahmed AA; Neidle S
Molecules; 2020 Nov; 25(22):. PubMed ID: 33227941
[TBL] [Abstract][Full Text] [Related]
3. Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule.
Marchetti C; Zyner KG; Ohnmacht SA; Robson M; Haider SM; Morton JP; Marsico G; Vo T; Laughlin-Toth S; Ahmed AA; Di Vita G; Pazitna I; Gunaratnam M; Besser RJ; Andrade ACG; Diocou S; Pike JA; Tannahill D; Pedley RB; Evans TRJ; Wilson WD; Balasubramanian S; Neidle S
J Med Chem; 2018 Mar; 61(6):2500-2517. PubMed ID: 29356532
[TBL] [Abstract][Full Text] [Related]
4. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
Rajabpour A; Afgar A; Mahmoodzadeh H; Radfar JE; Rajaei F; Teimoori-Toolabi L
Cancer Chemother Pharmacol; 2017 Oct; 80(4):765-775. PubMed ID: 28887583
[TBL] [Abstract][Full Text] [Related]
5. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
[TBL] [Abstract][Full Text] [Related]
6. A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer.
Ohnmacht SA; Marchetti C; Gunaratnam M; Besser RJ; Haider SM; Di Vita G; Lowe HL; Mellinas-Gomez M; Diocou S; Robson M; Šponer J; Islam B; Pedley RB; Hartley JA; Neidle S
Sci Rep; 2015 Jun; 5():11385. PubMed ID: 26077929
[TBL] [Abstract][Full Text] [Related]
7. Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis.
Nakai Y; Otsuka M; Hoshida Y; Tada M; Komatsu Y; Kawabe T; Omata M
Oncol Rep; 2005 Nov; 14(5):1263-7. PubMed ID: 16211294
[TBL] [Abstract][Full Text] [Related]
8. Targeting pancreatic cancer with a G-quadruplex ligand.
Gunaratnam M; de la Fuente M; Hampel SM; Todd AK; Reszka AP; Schätzlein A; Neidle S
Bioorg Med Chem; 2011 Dec; 19(23):7151-7. PubMed ID: 22041170
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells.
Micco M; Collie GW; Dale AG; Ohnmacht SA; Pazitna I; Gunaratnam M; Reszka AP; Neidle S
J Med Chem; 2013 Apr; 56(7):2959-74. PubMed ID: 23514618
[TBL] [Abstract][Full Text] [Related]
10. A naphthalene diimide G-quadruplex ligand inhibits cell growth and down-regulates BCL-2 expression in an imatinib-resistant gastrointestinal cancer cell line.
Gunaratnam M; Collie GW; Reszka AP; Todd AK; Parkinson GN; Neidle S
Bioorg Med Chem; 2018 Jul; 26(11):2958-2964. PubMed ID: 29724653
[TBL] [Abstract][Full Text] [Related]
11. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
Park SH; Sung JH; Chung N
Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer.
Akada M; Crnogorac-Jurcevic T; Lattimore S; Mahon P; Lopes R; Sunamura M; Matsuno S; Lemoine NR
Clin Cancer Res; 2005 Apr; 11(8):3094-101. PubMed ID: 15837765
[TBL] [Abstract][Full Text] [Related]
13. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
[TBL] [Abstract][Full Text] [Related]
14. Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells.
Hampel SM; Sidibe A; Gunaratnam M; Riou JF; Neidle S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6459-63. PubMed ID: 20932753
[TBL] [Abstract][Full Text] [Related]
15. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles.
Chen Z; Zhao L; Shi K; Chen B
Clin Lab; 2018 May; 64(5):749-757. PubMed ID: 29739052
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
17. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
19. A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance.
Lee HS; Park SB; Kim SA; Kwon SK; Cha H; Lee DY; Ro S; Cho JM; Song SY
Sci Rep; 2017 Jan; 7():41615. PubMed ID: 28134290
[TBL] [Abstract][Full Text] [Related]
20. The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.
Köpper F; Binkowski AM; Bierwirth C; Dobbelstein M
Cell Cycle; 2014; 13(6):884-9. PubMed ID: 24556918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
